Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raghavan

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-upJ A Levi, D Thomson, T Sandeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.
British Journal of Urology|June 1, 1988
Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been definedD Raghavan, B Colls, J Levi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, J Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tractB L Hillcoat, D Raghavan, J Matthews, et al.
Thorax|May 1, 1985
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancerR Stuart-Harris, R M Fox, D Raghavan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1987
Chemotherapy for small cell lung cancer: induction and reinduction with VOCAR Stuart-Harris, D Raghavan, R M Fox, et al.
The Journal of Urology|October 12, 2005
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastasesD Raghavan, L J Brandes, K Klapp, et al.
Progress in Clinical and Biological Research|January 1, 1986
Response criteria phase II/phase III invasive bladder cancerA T Van Oosterom, H Akaza, R Hall, et al.
British Journal of Urology|August 1, 1992
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)S D Fosså, S J Harland, S B Kaye, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-upJ A Levi, D Thomson, T Sandeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.
British Journal of Urology|June 1, 1988
Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been definedD Raghavan, B Colls, J Levi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, J Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tractB L Hillcoat, D Raghavan, J Matthews, et al.
Thorax|May 1, 1985
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancerR Stuart-Harris, R M Fox, D Raghavan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1987
Chemotherapy for small cell lung cancer: induction and reinduction with VOCAR Stuart-Harris, D Raghavan, R M Fox, et al.
The Journal of Urology|October 12, 2005
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastasesD Raghavan, L J Brandes, K Klapp, et al.
Progress in Clinical and Biological Research|January 1, 1986
Response criteria phase II/phase III invasive bladder cancerA T Van Oosterom, H Akaza, R Hall, et al.
British Journal of Urology|August 1, 1992
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)S D Fosså, S J Harland, S B Kaye, et al.
Pageof 20